Volume 22, Number 3—March 2016
CME ACTIVITY - Synopsis
Epidemiology of Histoplasmosis Outbreaks, United States, 1938–2013
Kaitlin Benedict
and Rajal K. Mody
and Rajal K. Mody
Table 1
Antifungal drug treatments, hospitalizations, and deaths resulting from histoplasmosis outbreaks, by decade, United States, 1938–2013*
| Decade | No. (%) patients |
||
|---|---|---|---|
| Treated | Hospitalized | Died | |
| 1938–1949 |
0 |
57 (64.8) |
1 (1.7) |
| 1950–1959 |
7 (21.9) |
28 (37.3) |
4 (3.3) |
| 1960–1969 |
7 (6.5) |
24 (48.0) |
5 (2.9) |
| 1970–1979 |
50 (5.5) |
17 (3.7) |
15 (1.8) |
| 1980–1989 |
10 (4.5) |
72 (27.5) |
0 (0.0) |
| 1990–1999 | 14 (20.6) | 38 (22.1) | 0 (0.0) |
| 2000–2013 |
32 (6.8) |
29 (4.1) |
0 (0.0) |
| Total | 120 (6.7) | 265 (14.7) | 25 (1.1) |
*Percentages are of reported cases. Number and percent of cases from outbreaks were included when information was available.
Page created: February 11, 2016
Page updated: February 11, 2016
Page reviewed: February 11, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.